Latest filing published 13 Feb 2026 for Coeptis Therapeutics Holdings, Inc., €51k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Gene Salkind (board member) discloses dealings in 4 companies, chiefly Mobiquity Technologies, Inc., Upexi, Inc. and Z Squared Inc. We count 40 filings; the first trade dates from 14 January 2019 and the latest from 11 February 2026.
Purchases make up the whole of the open-market record (15 purchases, €7.4M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 18 share grants and 3 option exercises.
The median purchase comes to €304k. Clusters matter here: 3 out of 12 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 13 February 2026, reports a share grant in Z Squared Inc. The last insider purchase was made public on 21 November 2025, 336 days ago. Typically, a trade is published a median of 5 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations